The global market for Precision Oncology was valued at US$ 114460 million in the year 2024 and is projected to reach a revised size of US$ 218550 million by 2031, growing at a CAGR of 9.8% during the forecast period.

Precision Oncology Market

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

This report aims to provide a comprehensive presentation of the global market for Precision Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Oncology.

The Precision Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Precision Oncology Market Report

Report Metric	Details
Report Name	Precision Oncology Market
Accounted market size in year	US$ 114460 million
Forecasted market size in 2031	US$ 218550 million
CAGR	9.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diagnostics Therapeutics
Segment by Application	Pharmaceutical & Biotechnology Companies Hospitals & Diagnostic Laboratories Healthcare Data Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America, QIAGEN, Rain Oncology, Relay Therapeutics, Strata Oncology, Inc., Thermo Fisher Scientific Inc., Variantyx, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Precision Oncology Market growing?

Ans: The Precision Oncology Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Precision Oncology Market size in 2031?

Ans: The Precision Oncology Market size in 2031 will be US$ 218550 million.

Who are the main players in the Precision Oncology Market report?

Ans: The main players in the Precision Oncology Market are Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America, QIAGEN, Rain Oncology, Relay Therapeutics, Strata Oncology, Inc., Thermo Fisher Scientific Inc., Variantyx, Inc.

What are the Application segmentation covered in the Precision Oncology Market report?

Ans: The Applications covered in the Precision Oncology Market report are Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Healthcare Data Companies

What are the Type segmentation covered in the Precision Oncology Market report?

Ans: The Types covered in the Precision Oncology Market report are Diagnostics, Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnostics

1.2.3 Therapeutics

1.3 Market by Application

1.3.1 Global Precision Oncology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Hospitals & Diagnostic Laboratories

1.3.4 Healthcare Data Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Precision Oncology Market Perspective (2020-2031)

2.2 Global Precision Oncology Growth Trends by Region

2.2.1 Global Precision Oncology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Precision Oncology Historic Market Size by Region (2020-2025)

2.2.3 Precision Oncology Forecasted Market Size by Region (2026-2031)

2.3 Precision Oncology Market Dynamics

2.3.1 Precision Oncology Industry Trends

2.3.2 Precision Oncology Market Drivers

2.3.3 Precision Oncology Market Challenges

2.3.4 Precision Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Precision Oncology Players by Revenue

3.1.1 Global Top Precision Oncology Players by Revenue (2020-2025)

3.1.2 Global Precision Oncology Revenue Market Share by Players (2020-2025)

3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Precision Oncology Revenue

3.4 Global Precision Oncology Market Concentration Ratio

3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2024

3.5 Global Key Players of Precision Oncology Head office and Area Served

3.6 Global Key Players of Precision Oncology, Product and Application

3.7 Global Key Players of Precision Oncology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Oncology Breakdown Data by Type

4.1 Global Precision Oncology Historic Market Size by Type (2020-2025)

4.2 Global Precision Oncology Forecasted Market Size by Type (2026-2031)

5 Precision Oncology Breakdown Data by Application

5.1 Global Precision Oncology Historic Market Size by Application (2020-2025)

5.2 Global Precision Oncology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Precision Oncology Market Size (2020-2031)

6.2 North America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Precision Oncology Market Size by Country (2020-2025)

6.4 North America Precision Oncology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Precision Oncology Market Size (2020-2031)

7.2 Europe Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Precision Oncology Market Size by Country (2020-2025)

7.4 Europe Precision Oncology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Precision Oncology Market Size (2020-2031)

8.2 Asia-Pacific Precision Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Precision Oncology Market Size by Region (2020-2025)

8.4 Asia-Pacific Precision Oncology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Precision Oncology Market Size (2020-2031)

9.2 Latin America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Precision Oncology Market Size by Country (2020-2025)

9.4 Latin America Precision Oncology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Precision Oncology Market Size (2020-2031)

10.2 Middle East & Africa Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Precision Oncology Market Size by Country (2020-2025)

10.4 Middle East & Africa Precision Oncology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Acrivon Therapeutics

11.1.1 Acrivon Therapeutics Company Details

11.1.2 Acrivon Therapeutics Business Overview

11.1.3 Acrivon Therapeutics Precision Oncology Introduction

11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025)

11.1.5 Acrivon Therapeutics Recent Development

11.2 Bio-Serv

11.2.1 Bio-Serv Company Details

11.2.2 Bio-Serv Business Overview

11.2.3 Bio-Serv Precision Oncology Introduction

11.2.4 Bio-Serv Revenue in Precision Oncology Business (2020-2025)

11.2.5 Bio-Serv Recent Development

11.3 Exact Sciences Corporation

11.3.1 Exact Sciences Corporation Company Details

11.3.2 Exact Sciences Corporation Business Overview

11.3.3 Exact Sciences Corporation Precision Oncology Introduction

11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025)

11.3.5 Exact Sciences Corporation Recent Development

11.4 Illumina, Inc.

11.4.1 Illumina, Inc. Company Details

11.4.2 Illumina, Inc. Business Overview

11.4.3 Illumina, Inc. Precision Oncology Introduction

11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2020-2025)

11.4.5 Illumina, Inc. Recent Development

11.5 Invitae Corporation

11.5.1 Invitae Corporation Company Details

11.5.2 Invitae Corporation Business Overview

11.5.3 Invitae Corporation Precision Oncology Introduction

11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2020-2025)

11.5.5 Invitae Corporation Recent Development

11.6 Laboratory Corporation of America

11.6.1 Laboratory Corporation of America Company Details

11.6.2 Laboratory Corporation of America Business Overview

11.6.3 Laboratory Corporation of America Precision Oncology Introduction

11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025)

11.6.5 Laboratory Corporation of America Recent Development

11.7 QIAGEN

11.7.1 QIAGEN Company Details

11.7.2 QIAGEN Business Overview

11.7.3 QIAGEN Precision Oncology Introduction

11.7.4 QIAGEN Revenue in Precision Oncology Business (2020-2025)

11.7.5 QIAGEN Recent Development

11.8 Rain Oncology

11.8.1 Rain Oncology Company Details

11.8.2 Rain Oncology Business Overview

11.8.3 Rain Oncology Precision Oncology Introduction

11.8.4 Rain Oncology Revenue in Precision Oncology Business (2020-2025)

11.8.5 Rain Oncology Recent Development

11.9 Relay Therapeutics

11.9.1 Relay Therapeutics Company Details

11.9.2 Relay Therapeutics Business Overview

11.9.3 Relay Therapeutics Precision Oncology Introduction

11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2020-2025)

11.9.5 Relay Therapeutics Recent Development

11.10 Strata Oncology, Inc.

11.10.1 Strata Oncology, Inc. Company Details

11.10.2 Strata Oncology, Inc. Business Overview

11.10.3 Strata Oncology, Inc. Precision Oncology Introduction

11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025)

11.10.5 Strata Oncology, Inc. Recent Development

11.11 Thermo Fisher Scientific Inc.

11.11.1 Thermo Fisher Scientific Inc. Company Details

11.11.2 Thermo Fisher Scientific Inc. Business Overview

11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction

11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025)

11.11.5 Thermo Fisher Scientific Inc. Recent Development

11.12 Variantyx, Inc.

11.12.1 Variantyx, Inc. Company Details

11.12.2 Variantyx, Inc. Business Overview

11.12.3 Variantyx, Inc. Precision Oncology Introduction

11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025)

11.12.5 Variantyx, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Exact Sciences Corporation

Illumina Inc

Invitae Corporation

Laboratory Corporation of America

Qiagen NV

Rain Oncology

Relay Therapeutics

Thermo Fisher Scientific Inc

Variantyx

Acrivon Therapeutics

Bio-Serv

Strata Oncology, Inc.

List of Tables

Table 1. Global Precision Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnostics

Table 3. Key Players of Therapeutics

Table 4. Global Precision Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Precision Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Precision Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Precision Oncology Market Share by Region (2020-2025)

Table 8. Global Precision Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Precision Oncology Market Share by Region (2026-2031)

Table 10. Precision Oncology Market Trends

Table 11. Precision Oncology Market Drivers

Table 12. Precision Oncology Market Challenges

Table 13. Precision Oncology Market Restraints

Table 14. Global Precision Oncology Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Precision Oncology Market Share by Players (2020-2025)

Table 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)

Table 17. Ranking of Global Top Precision Oncology Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Precision Oncology Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Precision Oncology, Headquarters and Area Served

Table 20. Global Key Players of Precision Oncology, Product and Application

Table 21. Global Key Players of Precision Oncology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Precision Oncology Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Precision Oncology Revenue Market Share by Type (2020-2025)

Table 25. Global Precision Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Precision Oncology Revenue Market Share by Type (2026-2031)

Table 27. Global Precision Oncology Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Precision Oncology Revenue Market Share by Application (2020-2025)

Table 29. Global Precision Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Precision Oncology Revenue Market Share by Application (2026-2031)

Table 31. North America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Precision Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Precision Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Precision Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Precision Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Precision Oncology Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Precision Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Precision Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Acrivon Therapeutics Company Details

Table 47. Acrivon Therapeutics Business Overview

Table 48. Acrivon Therapeutics Precision Oncology Product

Table 49. Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 50. Acrivon Therapeutics Recent Development

Table 51. Bio-Serv Company Details

Table 52. Bio-Serv Business Overview

Table 53. Bio-Serv Precision Oncology Product

Table 54. Bio-Serv Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 55. Bio-Serv Recent Development

Table 56. Exact Sciences Corporation Company Details

Table 57. Exact Sciences Corporation Business Overview

Table 58. Exact Sciences Corporation Precision Oncology Product

Table 59. Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 60. Exact Sciences Corporation Recent Development

Table 61. Illumina, Inc. Company Details

Table 62. Illumina, Inc. Business Overview

Table 63. Illumina, Inc. Precision Oncology Product

Table 64. Illumina, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 65. Illumina, Inc. Recent Development

Table 66. Invitae Corporation Company Details

Table 67. Invitae Corporation Business Overview

Table 68. Invitae Corporation Precision Oncology Product

Table 69. Invitae Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 70. Invitae Corporation Recent Development

Table 71. Laboratory Corporation of America Company Details

Table 72. Laboratory Corporation of America Business Overview

Table 73. Laboratory Corporation of America Precision Oncology Product

Table 74. Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 75. Laboratory Corporation of America Recent Development

Table 76. QIAGEN Company Details

Table 77. QIAGEN Business Overview

Table 78. QIAGEN Precision Oncology Product

Table 79. QIAGEN Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 80. QIAGEN Recent Development

Table 81. Rain Oncology Company Details

Table 82. Rain Oncology Business Overview

Table 83. Rain Oncology Precision Oncology Product

Table 84. Rain Oncology Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 85. Rain Oncology Recent Development

Table 86. Relay Therapeutics Company Details

Table 87. Relay Therapeutics Business Overview

Table 88. Relay Therapeutics Precision Oncology Product

Table 89. Relay Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 90. Relay Therapeutics Recent Development

Table 91. Strata Oncology, Inc. Company Details

Table 92. Strata Oncology, Inc. Business Overview

Table 93. Strata Oncology, Inc. Precision Oncology Product

Table 94. Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 95. Strata Oncology, Inc. Recent Development

Table 96. Thermo Fisher Scientific Inc. Company Details

Table 97. Thermo Fisher Scientific Inc. Business Overview

Table 98. Thermo Fisher Scientific Inc. Precision Oncology Product

Table 99. Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 100. Thermo Fisher Scientific Inc. Recent Development

Table 101. Variantyx, Inc. Company Details

Table 102. Variantyx, Inc. Business Overview

Table 103. Variantyx, Inc. Precision Oncology Product

Table 104. Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)

Table 105. Variantyx, Inc. Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Precision Oncology Picture

Figure 2. Global Precision Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Precision Oncology Market Share by Type: 2024 VS 2031

Figure 4. Diagnostics Features

Figure 5. Therapeutics Features

Figure 6. Global Precision Oncology Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Precision Oncology Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical & Biotechnology Companies Case Studies

Figure 9. Hospitals & Diagnostic Laboratories Case Studies

Figure 10. Healthcare Data Companies Case Studies

Figure 11. Precision Oncology Report Years Considered

Figure 12. Global Precision Oncology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Precision Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Precision Oncology Market Share by Region: 2024 VS 2031

Figure 15. Global Precision Oncology Market Share by Players in 2024

Figure 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Precision Oncology Revenue in 2024

Figure 18. North America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Precision Oncology Market Share by Country (2020-2031)

Figure 20. United States Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Precision Oncology Market Share by Country (2020-2031)

Figure 24. Germany Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Precision Oncology Market Share by Region (2020-2031)

Figure 32. China Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Precision Oncology Market Share by Country (2020-2031)

Figure 40. Mexico Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Precision Oncology Market Share by Country (2020-2031)

Figure 44. Turkey Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Acrivon Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 48. Bio-Serv Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 49. Exact Sciences Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 50. Illumina, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 51. Invitae Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 52. Laboratory Corporation of America Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 53. QIAGEN Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 54. Rain Oncology Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 55. Relay Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 56. Strata Oncology, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 58. Variantyx, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions